121 related articles for article (PubMed ID: 8494693)
1. Radiation-induced transient cisplatin resistance in murine fibrosarcoma cells associated with elevated metallothionein content.
Eichholtz-Wirth H; Reidel G; Hietel B
Br J Cancer; 1993 May; 67(5):1001-6. PubMed ID: 8494693
[TBL] [Abstract][Full Text] [Related]
2. Transient cisplatin-resistant murine fibrosarcoma cell characterized by increased metallothionein content.
Eichholtz-Wirth H; Born R; Reidel G; Hietel B
J Cancer Res Clin Oncol; 1993; 119(4):227-33. PubMed ID: 8423198
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin resistance in mouse fibrosarcoma cells after low-dose irradiation in vitro and in vivo.
Eichholtz-Wirth H; Hietel B
Br J Cancer; 1994 Oct; 70(4):579-84. PubMed ID: 7522509
[TBL] [Abstract][Full Text] [Related]
4. Reversal of radiation-induced cisplatin resistance in murine fibrosarcoma cells by selective modulation of the cyclic GMP-dependent transduction pathway.
Eichholtz-Wirth H
Br J Cancer; 1995 Aug; 72(2):287-92. PubMed ID: 7640207
[TBL] [Abstract][Full Text] [Related]
5. Restoration of Cisplatin sensitivity by mild hyperthermia in radiation-induced Cisplatin-resistant mouse fibrosarcoma cells.
Eichholtzwirth H
Int J Oncol; 1995 Oct; 7(4):935-9. PubMed ID: 21552925
[TBL] [Abstract][Full Text] [Related]
6. Zinc treatment, metallothionein expression, and resistance to cisplatin in mouse melanoma cells.
Koropatnick J; Pearson J
Somat Cell Mol Genet; 1990 Nov; 16(6):529-37. PubMed ID: 2267627
[TBL] [Abstract][Full Text] [Related]
7. Quantitative distinction of cisplatin-sensitive and -resistant mouse fibrosarcoma cells grown in multicell tumor spheroids.
Frenzel KR; Saller RM; Kummermehr J; Schultz-Hector S
Cancer Res; 1995 Jan; 55(2):386-91. PubMed ID: 7812971
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells.
Andrews PA; Murphy MP; Howell SB
Cancer Chemother Pharmacol; 1987; 19(2):149-54. PubMed ID: 3568272
[TBL] [Abstract][Full Text] [Related]
9. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
Mellish KJ; Kelland LR; Harrap KR
Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478
[TBL] [Abstract][Full Text] [Related]
10. Basal and zinc-induced metallothionein in resistance to cadmium, cisplatin, zinc, and tertbutyl hydroperoxide: studies using MT knockout and antisense-downregulated MT in mammalian cells.
Kennette W; Collins OM; Zalups RK; Koropatnick J
Toxicol Sci; 2005 Dec; 88(2):602-13. PubMed ID: 16150881
[TBL] [Abstract][Full Text] [Related]
11. Altered cisplatin and cadmium resistance and cell survival in Chinese hamster ovary cells expressing mouse metallothionein.
Koropatnick J; Pearson J
Mol Pharmacol; 1993 Jul; 44(1):44-50. PubMed ID: 8341278
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines.
Kondo Y; Kuo SM; Watkins SC; Lazo JS
Cancer Res; 1995 Feb; 55(3):474-7. PubMed ID: 7834610
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins.
Siegsmund MJ; Marx C; Seemann O; Schummer B; Steidler A; Toktomambetova L; Köhrmann KU; Rassweiler J; Alken P
Urol Res; 1999 Jun; 27(3):157-63. PubMed ID: 10422815
[TBL] [Abstract][Full Text] [Related]
14. Isolation of V79 fibroblast cell lines containing elevated metallothionein levels that have increased resistance to the cytotoxic effects of ultraviolet-A radiation.
Dudek EJ; Peak JG; Roth RM; Peak MJ
Photochem Photobiol; 1993 Dec; 58(6):836-40. PubMed ID: 8310006
[TBL] [Abstract][Full Text] [Related]
15. Enrichment for metallothionein does not confer resistance to cisplatin in transfected NIH/3T3 cells.
Morton KA; Jones BJ; Sohn MH; Datz FL; Lynch RE
J Pharmacol Exp Ther; 1993 Nov; 267(2):697-702. PubMed ID: 8246143
[TBL] [Abstract][Full Text] [Related]
16. Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum.
Ikeda K; Miura K; Himeno S; Imura N; Naganuma A
Mol Cell Biochem; 2001 Mar; 219(1-2):51-6. PubMed ID: 11354253
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
Dempke WC; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Hill BT
Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
[TBL] [Abstract][Full Text] [Related]
18. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.
Kasahara K; Fujiwara Y; Nishio K; Ohmori T; Sugimoto Y; Komiya K; Matsuda T; Saijo N
Cancer Res; 1991 Jun; 51(12):3237-42. PubMed ID: 1645616
[TBL] [Abstract][Full Text] [Related]
19. The characterization of two human cervical carcinoma HeLa sublines resistant to cisplatin.
Osmak M; Eljuga D
Res Exp Med (Berl); 1993; 193(6):389-96. PubMed ID: 8122044
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre-exposed in vitro to either X-irradiation or cisplatin.
Bedford P; Shellard SA; Walker MC; Whelan RD; Masters JR; Hill BT
Int J Cancer; 1987 Nov; 40(5):681-6. PubMed ID: 3679594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
